Acadia Healthcare Company, Inc. (ACHC) Receives Average Recommendation of “Buy” from Brokerages

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) have received a consensus recommendation of “Buy” from the sixteen research firms that are covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, four have given a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is $57.27.

ACHC has been the topic of several research reports. BidaskClub lowered shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Friday, August 18th. Zacks Investment Research lowered shares of Acadia Healthcare from a “buy” rating to a “hold” rating in a research report on Tuesday, August 1st. William Blair started coverage on shares of Acadia Healthcare in a research report on Tuesday, July 18th. They set an “outperform” rating on the stock. Jefferies Group LLC set a $55.00 target price on shares of Acadia Healthcare and gave the stock a “buy” rating in a research report on Thursday, June 1st. Finally, KeyCorp restated an “overweight” rating and set a $51.00 target price on shares of Acadia Healthcare in a research report on Thursday, June 1st.

In other news, EVP Christopher L. Howard sold 53,713 shares of Acadia Healthcare stock in a transaction dated Tuesday, August 22nd. The shares were sold at an average price of $50.69, for a total value of $2,722,711.97. Following the completion of the transaction, the executive vice president now directly owns 147,286 shares of the company’s stock, valued at approximately $7,465,927.34. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Reeve B. Waud sold 50,000 shares of Acadia Healthcare stock in a transaction dated Thursday, June 22nd. The shares were sold at an average price of $47.51, for a total transaction of $2,375,500.00. The disclosure for this sale can be found here. Insiders sold a total of 3,185,693 shares of company stock valued at $162,606,599 over the last ninety days. Company insiders own 11.10% of the company’s stock.

Institutional investors have recently bought and sold shares of the business. Russell Investments Group Ltd. boosted its stake in Acadia Healthcare by 43.9% during the 1st quarter. Russell Investments Group Ltd. now owns 221,649 shares of the company’s stock valued at $9,664,000 after purchasing an additional 67,665 shares during the period. BNP Paribas Arbitrage SA boosted its stake in Acadia Healthcare by 2,358.9% during the 2nd quarter. BNP Paribas Arbitrage SA now owns 28,843 shares of the company’s stock valued at $1,424,000 after purchasing an additional 27,670 shares during the period. UBS Asset Management Americas Inc. boosted its stake in Acadia Healthcare by 21.6% during the 1st quarter. UBS Asset Management Americas Inc. now owns 332,355 shares of the company’s stock valued at $14,491,000 after purchasing an additional 59,001 shares during the period. Schwab Charles Investment Management Inc. boosted its stake in Acadia Healthcare by 2.8% during the 1st quarter. Schwab Charles Investment Management Inc. now owns 290,396 shares of the company’s stock valued at $12,662,000 after purchasing an additional 7,985 shares during the period. Finally, Sheets Smith Wealth Management boosted its stake in Acadia Healthcare by 11.1% during the 2nd quarter. Sheets Smith Wealth Management now owns 9,094 shares of the company’s stock valued at $449,000 after purchasing an additional 910 shares during the period.

COPYRIGHT VIOLATION WARNING: This news story was posted by Transcript Daily and is the property of of Transcript Daily. If you are accessing this news story on another publication, it was stolen and reposted in violation of U.S. and international copyright and trademark laws. The legal version of this news story can be accessed at https://transcriptdaily.com/2017/09/17/acadia-healthcare-company-inc-achc-receives-average-recommendation-of-buy-from-brokerages.html.

Acadia Healthcare (ACHC) opened at 46.78 on Friday. Acadia Healthcare has a one year low of $32.54 and a one year high of $54.34. The stock’s 50 day moving average price is $48.96 and its 200 day moving average price is $45.91. The firm has a market capitalization of $4.11 billion, a PE ratio of 514.07 and a beta of 1.14.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Thursday, July 27th. The company reported $0.66 EPS for the quarter, beating the consensus estimate of $0.65 by $0.01. The business had revenue of $715.90 million for the quarter, compared to analyst estimates of $717.38 million. Acadia Healthcare had a net margin of 0.30% and a return on equity of 8.69%. The company’s quarterly revenue was down 5.4% on a year-over-year basis. During the same period in the prior year, the business earned $0.73 earnings per share. Analysts expect that Acadia Healthcare will post $2.45 EPS for the current year.

About Acadia Healthcare

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Analyst Recommendations for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply